Published in Infect Immun on June 01, 2003
CD8(+) T cells restrict Yersinia pseudotuberculosis infection: bypass of anti-phagocytosis by targeting antigen-presenting cells. PLoS Pathog (2009) 1.24
Enteric pathogens as vaccine vectors for foreign antigen delivery. Infect Immun (2004) 1.17
Systematic analysis of the SsrAB virulon of Salmonella enterica. Infect Immun (2009) 1.10
A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis. Infect Immun (2011) 0.96
YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection. Infect Immun (2010) 0.92
The Yersinia enterocolitica invasin protein promotes major histocompatibility complex class I- and class II-restricted T-cell responses. Infect Immun (2006) 0.90
Expression of a functional secreted YopN-TyeA hybrid protein in Yersinia pestis is the result of a +1 translational frameshift event. J Bacteriol (2004) 0.90
Oral vaccination with recombinant Yersinia enterocolitica expressing hybrid type III proteins protects gerbils from amebic liver abscess. Infect Immun (2004) 0.88
Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation. Infect Immun (2010) 0.85
Optimization of a type III secretion system-based Pseudomonas aeruginosa live vector for antigen delivery. Clin Vaccine Immunol (2007) 0.84
Direct injection of functional single-domain antibodies from E. coli into human cells. PLoS One (2010) 0.81
LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague. Infect Immun (2014) 0.79
Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague. Vaccine (2015) 0.76
A bacterial type III secretion-based protein delivery tool for broad applications in cell biology. J Cell Biol (2015) 0.75
Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J Bacteriol (1978) 75.38
Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev (1998) 17.27
Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol (1999) 7.18
Supramolecular structure of the Salmonella typhimurium type III protein secretion system. Science (1998) 6.55
Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J (1994) 6.37
Sequence analysis of peptides bound to MHC class II molecules. Nature (1991) 5.99
Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells. Mol Microbiol (1994) 5.82
The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev (1998) 5.78
Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia. Science (1990) 5.21
The cytotoxic protein YopE of Yersinia obstructs the primary host defence. Mol Microbiol (1990) 5.09
Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med (1993) 4.99
Inhibition of phagocytosis in Yersinia pseudotuberculosis: a virulence plasmid-encoded ability involving the Yop2b protein. Infect Immun (1988) 4.61
Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption. Infect Immun (1991) 4.46
Identification of the YopE and YopH domains required for secretion and internalization into the cytosol of macrophages, using the cyaA gene fusion approach. Proc Natl Acad Sci U S A (1995) 4.36
Molecular cloning of the temperature-inducible outer membrane protein 1 of Yersinia pseudotuberculosis. Infect Immun (1984) 4.07
The invasion-associated type III system of Salmonella typhimurium directs the translocation of Sip proteins into the host cell. Mol Microbiol (1997) 3.42
A secreted protein kinase of Yersinia pseudotuberculosis is an indispensable virulence determinant. Nature (1993) 3.40
The adenovirus E4-6/7 protein transactivates the E2 promoter by inducing dimerization of a heteromeric E2F complex. Mol Cell Biol (1994) 2.99
Electron microscopic evidence for in vivo extracellular localization of Yersinia pseudotuberculosis harboring the pYV plasmid. Infect Immun (1990) 2.95
Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature (1991) 2.83
The gene coding for protein p60 of Listeria monocytogenes and its use as a specific probe for Listeria monocytogenes. Infect Immun (1990) 2.69
CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J Exp Med (1992) 2.62
The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Mol Microbiol (2000) 2.56
GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure. Mol Microbiol (2000) 2.56
Type III secretion systems: machines to deliver bacterial proteins into eukaryotic cells? Trends Microbiol (1997) 2.44
Plasmid-mediated resistance to phagocytosis in Yersinia enterocolitica. Infect Immun (1987) 2.43
The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions. EMBO J (1997) 2.32
Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes. Nat Biotechnol (1998) 2.25
Delineation and mutational analysis of the Yersinia pseudotuberculosis YopE domains which mediate translocation across bacterial and eukaryotic cellular membranes. J Bacteriol (1996) 2.11
Targeting of Yersinia Yop proteins into the cytosol of HeLa cells: one-step translocation of YopE across bacterial and eukaryotic membranes is dependent on SycE chaperone. Mol Microbiol (1998) 2.09
Functional expression of B7/BB1 on activated T lymphocytes. J Exp Med (1993) 1.98
Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science (1998) 1.97
Role of Yops and adhesins in resistance of Yersinia enterocolitica to phagocytosis. Infect Immun (2002) 1.97
Characterization of the operon encoding the YpkA Ser/Thr protein kinase and the YopJ protein of Yersinia pseudotuberculosis. J Bacteriol (1994) 1.95
Interaction of Yersinia enterocolitica with macrophages leads to macrophage cell death through apoptosis. Infect Immun (1997) 1.85
Immunodominant and subdominant CTL responses to Listeria monocytogenes infection. J Immunol (1997) 1.83
A novel approach of direct ex vivo epitope mapping identifies dominant and subdominant CD4 and CD8 T cell epitopes from Listeria monocytogenes. J Immunol (2001) 1.75
YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane. Mol Microbiol (1997) 1.74
A distinctive role for the Yersinia protein kinase: actin binding, kinase activation, and cytoskeleton disruption. Proc Natl Acad Sci U S A (2000) 1.74
The Yersinia tyrosine phosphatase YopH targets a novel adhesion-regulated signalling complex in macrophages. Cell Microbiol (2000) 1.53
The cytotoxin YopT of Yersinia enterocolitica induces modification and cellular redistribution of the small GTP-binding protein RhoA. J Biol Chem (1999) 1.52
Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors. J Biotechnol (1996) 1.47
Virulence plasmid-encoded YopK is essential for Yersinia pseudotuberculosis to cause systemic infection in mice. Infect Immun (1995) 1.36
The endogenous pathway of MHC class II antigen presentation. Immunol Rev (1996) 1.34
YopH dephosphorylates Cas and Fyn-binding protein in macrophages. Microb Pathog (1999) 1.30
The Yersinia protein kinase A is a host factor inducible RhoA/Rac-binding virulence factor. J Biol Chem (2000) 1.27
In vitro and in vivo expression studies of yopE from Yersinia enterocolitica using the gfp reporter gene. Mol Microbiol (1998) 1.26
T cell responses to bacterial infection. Curr Opin Immunol (1999) 1.13
Salmonellae as oral vaccine carriers. Dev Biol Stand (1995) 1.07
Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing hybrid Yersinia type III proteins. J Immunol (2001) 1.07
Expression of the eukaryotic Trypanosoma cruzi CRA gene in Yersinia enterocolitica and induction of an immune response against CRA in mice. Infect Immun (1992) 1.07
Recombinant Yersinia YopT leads to uncoupling of RhoA-effector interaction. Infect Immun (2001) 1.07
Interactions of Salmonella with host cells: encounters of the closest kind. Proc Natl Acad Sci U S A (1998) 0.99
Yersinia enterocolitica-mediated translocation of defined fusion proteins to the cytosol of mammalian cells results in peptide-specific MHC class I-restricted antigen presentation. Eur J Immunol (2000) 0.95
Cross-presentation of Listeria monocytogenes-derived CD4 T cell epitopes. J Immunol (2002) 0.90
Live Salmonella vaccines as a route towards oral immunisation. Biologicals (1995) 0.90
Concomitant cytosolic delivery of two immunodominant listerial antigens by Salmonella enterica serovar typhimurium confers superior protection against murine listeriosis. Infect Immun (2002) 0.82
Protein delivery into eukaryotic cells by type III secretion machines. Nature (2006) 7.49
Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem Biol (2003) 2.61
Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J Exp Med (2002) 2.41
CD8alpha+ dendritic cells are required for efficient entry of Listeria monocytogenes into the spleen. Immunity (2006) 2.06
Translocation of surface-localized effectors in type III secretion. Proc Natl Acad Sci U S A (2011) 2.05
Carbon metabolism of intracellular bacterial pathogens and possible links to virulence. Nat Rev Microbiol (2010) 2.04
A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc Natl Acad Sci U S A (2006) 2.01
Molecular analysis of transport and oligomerization of the Yersinia enterocolitica adhesin YadA. J Bacteriol (2003) 1.96
The conserved plant sterility gene HAP2 functions after attachment of fusogenic membranes in Chlamydomonas and Plasmodium gametes. Genes Dev (2008) 1.95
Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. J Infect Dis (2009) 1.87
Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex). J Immunother (2010) 1.81
Contribution of the major secreted yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model. Infect Immun (2004) 1.73
Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4. Clin Cancer Res (2011) 1.70
Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Int J Med Microbiol (2010) 1.70
Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J Immunol (2002) 1.67
Phagocytosis of Aspergillus fumigatus conidia by murine macrophages involves recognition by the dectin-1 beta-glucan receptor and Toll-like receptor 2. Cell Microbiol (2006) 1.62
Detection of differences in the nucleotide and amino acid sequences of diphtheria toxin from Corynebacterium diphtheriae and Corynebacterium ulcerans causing extrapharyngeal infections. J Clin Microbiol (2003) 1.54
Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle. FEBS Lett (2007) 1.50
Regulation of type III secretion systems. Curr Opin Microbiol (2002) 1.48
Concerted actions of a thermo-labile regulator and a unique intergenic RNA thermosensor control Yersinia virulence. PLoS Pathog (2012) 1.45
Salicylidene acylhydrazides that affect type III protein secretion in Salmonella enterica serovar typhimurium. Antimicrob Agents Chemother (2007) 1.43
Deletion of the gliP gene of Aspergillus fumigatus results in loss of gliotoxin production but has no effect on virulence of the fungus in a low-dose mouse infection model. Mol Microbiol (2006) 1.42
A novel integrative and conjugative element (ICE) of Escherichia coli: the putative progenitor of the Yersinia high-pathogenicity island. Mol Microbiol (2004) 1.42
Yersinia high-pathogenicity island contributes to virulence in Escherichia coli causing extraintestinal infections. Infect Immun (2002) 1.41
Molecular characterization of type III secretion signals via analysis of synthetic N-terminal amino acid sequences. Mol Microbiol (2002) 1.40
YscP and YscU regulate substrate specificity of the Yersinia type III secretion system. J Bacteriol (2003) 1.39
Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages. J Immunol (2004) 1.38
Yersinia enterocolitica type III secretion depends on the proton motive force but not on the flagellar motor components MotA and MotB. Infect Immun (2004) 1.36
Growth, virulence, and immunogenicity of Listeria monocytogenes aro mutants. Infect Immun (2004) 1.34
Characterization of an iroBCDEN gene cluster on a transmissible plasmid of uropathogenic Escherichia coli: evidence for horizontal transfer of a chromosomal virulence factor. Infect Immun (2003) 1.33
A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence. Proc Natl Acad Sci U S A (2005) 1.31
Inhibition of type III secretion in Salmonella enterica serovar Typhimurium by small-molecule inhibitors. Antimicrob Agents Chemother (2007) 1.31
Classical diphtheria caused by Corynebacterium ulcerans in Germany: amino acid sequence differences between diphtheria toxins from Corynebacterium diphtheriae and C. ulcerans. Clin Infect Dis (2005) 1.30
Reassignment of enterobacter dissolvens to Enterobacter cloacae as E. cloacae subspecies dissolvens comb. nov. and emended description of Enterobacter asburiae and Enterobacter kobei. Syst Appl Microbiol (2005) 1.29
The Yersinia high-pathogenicity island (HPI): evolutionary and functional aspects. Int J Med Microbiol (2004) 1.29
Identification of a molecular target for the Yersinia protein kinase A. Mol Cell (2007) 1.29
Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients. Cancer Res (2012) 1.28
Proteolytic cleavage of the FlhB homologue YscU of Yersinia pseudotuberculosis is essential for bacterial survival but not for type III secretion. J Bacteriol (2002) 1.27
Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung. Curr Top Microbiol Immunol (2013) 1.26
NETs formed by human neutrophils inhibit growth of the pathogenic mold Aspergillus fumigatus. Microbes Infect (2010) 1.24
Visualisation of zebrafish infection by GFP-labelled Vibrio anguillarum. Microb Pathog (2004) 1.23
Expression of Pseudomonas aeruginosa exoS is controlled by quorum sensing and RpoS. Microbiology (2004) 1.22
Complete genome sequence of Yersinia enterocolitica subsp. palearctica serogroup O:3. J Bacteriol (2011) 1.21
Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis. J Infect Dis (2006) 1.20
Molecular evidence of nosocomial Pneumocystis jirovecii transmission among 16 patients after kidney transplantation. J Clin Microbiol (2008) 1.20
Detection of toxigenic Corynebacterium diphtheriae and Corynebacterium ulcerans strains by a novel real-time PCR. J Clin Microbiol (2008) 1.19
A dominant role of Toll-like receptor 4 in the signaling of apoptosis in bacteria-faced macrophages. J Immunol (2003) 1.19
"Staphylococcus pettenkoferi," a novel staphylococcal species isolated from clinical specimens. Diagn Microbiol Infect Dis (2002) 1.18
Regulation of Yersinia Yop-effector delivery by translocated YopE. Int J Med Microbiol (2007) 1.18
Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother (2004) 1.16
The Ser/Thr kinase activity of the Yersinia protein kinase A (YpkA) is necessary for full virulence in the mouse, mollifying phagocytes, and disrupting the eukaryotic cytoskeleton. Microb Pathog (2006) 1.13
Yersinia enterocolitica infection of mice reveals clonal invasion and abscess formation. Infect Immun (2007) 1.10
Evaluation of the novel Helicobacter pylori ClariRes real-time PCR assay for detection and clarithromycin susceptibility testing of H. pylori in stool specimens from symptomatic children. J Clin Microbiol (2007) 1.10
The YopD translocator of Yersinia pseudotuberculosis is a multifunctional protein comprised of discrete domains. J Bacteriol (2004) 1.10
Analysis of chaperone-dependent Yop secretion/translocation and effector function using a mini-virulence plasmid of Yersinia enterocolitica. Int J Med Microbiol (2003) 1.09
Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction. Cell Host Microbe (2012) 1.09
Metabolic adaptation of human pathogenic and related nonpathogenic bacteria to extra- and intracellular habitats. FEMS Microbiol Rev (2011) 1.08
Transcriptional responses of murine macrophages to infection with Yersinia enterocolitica. Cell Microbiol (2004) 1.08
Analysis of the regulation, expression, and localisation of the isocitrate lyase from Aspergillus fumigatus, a potential target for antifungal drug development. Fungal Genet Biol (2006) 1.07
Metabolic host responses to infection by intracellular bacterial pathogens. Front Cell Infect Microbiol (2013) 1.06
Gliotoxin production by clinical and environmental Aspergillus fumigatus strains. Int J Med Microbiol (2007) 1.04
Role of respiration in the germination process of the pathogenic mold Aspergillus fumigatus. Curr Microbiol (2007) 1.04
Novel highly sensitive IL-10-beta-lactamase reporter mouse reveals cells of the innate immune system as a substantial source of IL-10 in vivo. J Immunol (2011) 1.03
Contribution of toll-like receptors 2 and 4 in an oral Yersinia enterocolitica mouse infection model. Int J Med Microbiol (2003) 1.03
Evaluation of detection of Legionella spp. in water samples by fluorescence in situ hybridization, PCR amplification and bacterial culture. Int J Med Microbiol (2002) 1.02
Staphylococcus pettenkoferi sp. nov., a novel coagulase-negative staphylococcal species isolated from human clinical specimens. Int J Syst Evol Microbiol (2007) 1.02
Description of Enterobacter ludwigii sp. nov., a novel Enterobacter species of clinical relevance. Syst Appl Microbiol (2005) 1.02
Human dirofilariasis due to Dirofilaria repens mimicking a scrotal tumor. Urology (2008) 1.01
Two distinct coagulase-dependent barriers protect Staphylococcus aureus from neutrophils in a three dimensional in vitro infection model. PLoS Pathog (2012) 1.01
Generation of tumor antigen-specific T cell lines from pediatric patients with acute lymphoblastic leukemia--implications for immunotherapy. Clin Cancer Res (2013) 1.00
Irp9, encoded by the high-pathogenicity island of Yersinia enterocolitica, is able to convert chorismate into salicylate, the precursor of the siderophore yersiniabactin. J Bacteriol (2003) 1.00
Functional analysis of the YopE GTPase-activating protein (GAP) activity of Yersinia pseudotuberculosis. Cell Microbiol (2006) 1.00
On the role of specific chaperones, the specific ATPase, and the proton motive force in type III secretion. Int J Med Microbiol (2006) 0.99
Salicylanilides are potent inhibitors of type III secretion in Yersinia. Adv Exp Med Biol (2003) 0.98
Interaction between the Yersinia protein tyrosine phosphatase YopH and eukaryotic Cas/Fyb is an important virulence mechanism. Cell Microbiol (2003) 0.98
Characterisation of the phagocytic uptake of Aspergillus fumigatus conidia by macrophages. Microbes Infect (2007) 0.98
The membrane localization domain is required for intracellular localization and autoregulation of YopE in Yersinia pseudotuberculosis. Infect Immun (2009) 0.98
The RACK1 signaling scaffold protein selectively interacts with Yersinia pseudotuberculosis virulence function. PLoS One (2011) 0.98
Autoproteolysis of YscU of Yersinia pseudotuberculosis is important for regulation of expression and secretion of Yop proteins. J Bacteriol (2009) 0.97
Nod2 mediates susceptibility to Yersinia pseudotuberculosis in mice. PLoS One (2008) 0.97
Yersinia enterocolitica palearctica serobiotype O:3/4--a successful group of emerging zoonotic pathogens. BMC Genomics (2011) 0.97
Yersinia outer protein P inhibits CD8 T cell priming in the mouse infection model. J Immunol (2005) 0.96
Enterobacter hormaechei subsp. oharae subsp. nov., E. hormaechei subsp. hormaechei comb. nov., and E. hormaechei subsp. steigerwaltii subsp. nov., three new subspecies of clinical importance. J Clin Microbiol (2005) 0.95
Farnesol misplaces tip-localized Rho proteins and inhibits cell wall integrity signalling in Aspergillus fumigatus. Mol Microbiol (2010) 0.93
Horizontal transfer of Yersinia high-pathogenicity island by the conjugative RP4 attB target-presenting shuttle plasmid. Mol Microbiol (2005) 0.93
Neisseria meningitidis adhesin NadA targets beta1 integrins: functional similarity to Yersinia invasin. J Biol Chem (2011) 0.93
The transcription factor Lyl-1 regulates lymphoid specification and the maintenance of early T lineage progenitors. Nat Immunol (2012) 0.93
Bacterial delivery of functional messenger RNA to mammalian cells. Cell Microbiol (2005) 0.93
Induction of CD8+ T cell responses by Yersinia vaccine carrier strains. Vaccine (2005) 0.92
Bacterial toxins induce sustained mRNA expression of the silencing transcription factor klf2 via inactivation of RhoA and Rhophilin 1. Infect Immun (2009) 0.92
The proteasome pathway destabilizes Yersinia outer protein E and represses its antihost cell activities. J Immunol (2006) 0.91
Identification of novel virulence-associated genes via genome analysis of hypothetical genes. Infect Immun (2004) 0.91
Structural organization of the pFra virulence-associated plasmid of rhamnose-positive Yersinia pestis. Infect Immun (2004) 0.91
Improvement of reporter activity by IRES-mediated polycistronic reporter system. Nucleic Acids Res (2008) 0.90
A fundamental role of mAbp1 in neutrophils: impact on beta(2) integrin-mediated phagocytosis and adhesion in vivo. Blood (2009) 0.90